Silvia Brich

2.1k total citations
44 papers, 1.1k citations indexed

About

Silvia Brich is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Silvia Brich has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Silvia Brich's work include Sarcoma Diagnosis and Treatment (19 papers), Immunotherapy and Immune Responses (4 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Silvia Brich is often cited by papers focused on Sarcoma Diagnosis and Treatment (19 papers), Immunotherapy and Immune Responses (4 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). Silvia Brich collaborates with scholars based in Italy, United States and France. Silvia Brich's co-authors include Alessandro Gronchi, Paolo G. Casali, Silvia Stacchiotti, Silvana Pilotti, Tiziana Negri, Elena Tamborini, Fabio Bozzi, Elena Conca, Marco A. Pierotti and Carlo Morosi and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Silvia Brich

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Brich Italy 18 746 468 276 204 204 44 1.1k
Hongying Zhang China 20 751 1.0× 368 0.8× 402 1.5× 143 0.7× 323 1.6× 83 1.3k
Paul Chih-Hsueh Chen Taiwan 20 498 0.7× 325 0.7× 258 0.9× 109 0.5× 195 1.0× 48 1.0k
Charles Forscher United States 22 1.2k 1.6× 694 1.5× 340 1.2× 402 2.0× 372 1.8× 36 1.7k
Lu Xie China 15 626 0.8× 438 0.9× 433 1.6× 60 0.3× 190 0.9× 56 1.2k
Lorenzo D’Ambrosio Italy 18 777 1.0× 590 1.3× 337 1.2× 132 0.6× 138 0.7× 50 1.2k
Sebastian Dorin Asaftei Italy 9 535 0.7× 328 0.7× 252 0.9× 92 0.5× 129 0.6× 27 793
Paolo Cotzia United States 17 439 0.6× 363 0.8× 364 1.3× 42 0.2× 149 0.7× 34 1.1k
Konrad Ptaszyński Poland 16 369 0.5× 249 0.5× 184 0.7× 32 0.2× 225 1.1× 47 846
Kunkun Sun China 16 491 0.7× 402 0.9× 409 1.5× 43 0.2× 102 0.5× 71 1.2k

Countries citing papers authored by Silvia Brich

Since Specialization
Citations

This map shows the geographic impact of Silvia Brich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Brich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Brich more than expected).

Fields of papers citing papers by Silvia Brich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Brich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Brich. The network helps show where Silvia Brich may publish in the future.

Co-authorship network of co-authors of Silvia Brich

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Brich. A scholar is included among the top collaborators of Silvia Brich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Brich. Silvia Brich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santis, Francesca De, Silvia Brich, Andrea Vingiani, et al.. (2025). 43P Immunosuppressive microenvironment can be reverted by neoadjuvant chemotherapy in TNBC. ESMO Open. 10. 104202–104202.
2.
Callegaro, Dario, Felix Boakye Oppong, Axelle Nzokirantevye, et al.. (2025). CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS). Clinical Cancer Research. 31(15). 3239–3248.
3.
Carniti, Cristiana, Luca Agnelli, Silva Ljevar, et al.. (2024). Monocytes in leukapheresis products affect the outcome of CD19–targeted CAR T-cell therapy in patients with lymphoma. Blood Advances. 8(8). 1968–1980. 7 indexed citations
4.
Noviello, Teresa, Anna Maria Di Giacomo, Francesca Pia Caruso, et al.. (2023). Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial. Nature Communications. 14(1). 5914–5914. 18 indexed citations
5.
Zuco, Valentina, Sandro Pasquali, Monica Tortoreto, et al.. (2023). Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft. Disease Models & Mechanisms. 16(6). 5 indexed citations
6.
Kusamura, Shigeki, Adele Busico, Elena Conca, et al.. (2023). A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei. Biomedicines. 11(7). 2049–2049. 5 indexed citations
7.
Randon, Giovanni, Rossana Intini, Chiara Cremolini, et al.. (2021). Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. European Journal of Cancer. 161. 90–98. 15 indexed citations
8.
Minna, Emanuela, Silvia Brich, Katia Todoerti, et al.. (2020). Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers. 12(1). 112–112. 40 indexed citations
9.
Frapolli, Roberta, Ezia Bello, Ilaria Craparotta, et al.. (2019). Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas. Clinical Cancer Research. 25(24). 7565–7575. 20 indexed citations
10.
Bello, Ezia, Silvia Brich, Ilaria Craparotta, et al.. (2019). Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin. British Journal of Cancer. 121(6). 464–473. 12 indexed citations
11.
Cecco, Loris De, Matteo Dugo, Gian Paolo Dagrada, et al.. (2018). The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response. Cancer Communications. 38(1). 70–70. 23 indexed citations
12.
Mazzoni, Mara, Daniele Lecis, Emanuela Minna, et al.. (2018). Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cells. Cancer Letters. 442. 362–372. 14 indexed citations
13.
Stacchiotti, Silvia, Annalisa Astolfi, Alessandro Gronchi, et al.. (2016). Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial–Mesenchymal Transition–like Process and 22q Loss. Molecular Cancer Research. 14(9). 820–829. 23 indexed citations
14.
Stacchiotti, Silvia, Salvatore Provenzano, Gian Paolo Dagrada, et al.. (2016). Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database. Annals of Surgical Oncology. 23(9). 2735–2744. 51 indexed citations
15.
Dossi, Romina, Roberta Frapolli, Silvana Di Giandomenico, et al.. (2014). Antiangiogenic activity of trabectedin in myxoid liposarcoma: Involvement of host TIMP‐1 and TIMP‐2 and tumor thrombospondin‐1. International Journal of Cancer. 136(3). 721–729. 48 indexed citations
16.
Negri, Tiziana, Silvia Brich, Elena Conca, et al.. (2011). Receptor tyrosine kinase pathway analysis sheds light on similarities between clear‐cell sarcoma and metastatic melanoma. Genes Chromosomes and Cancer. 51(2). 111–126. 20 indexed citations
17.
Bozzi, Fabio, Elena Conca, Giacomo Manenti, et al.. (2011). High CD133 expression levels in gastrointestinal stromal tumors. Cytometry Part B Clinical Cytometry. 80B(4). 238–247. 11 indexed citations
18.
Negri, Tiziana, Emanuela Virdis, Silvia Brich, et al.. (2010). Functional Mapping of Receptor Tyrosine Kinases in Myxoid Liposarcoma. Clinical Cancer Research. 16(14). 3581–3593. 37 indexed citations
19.
Negri, Tiziana, Fabio Bozzi, Elena Conca, et al.. (2008). Oncogenic and ligand‐dependent activation of KIT/PDGFRA in surgical samples of imatinib‐treated gastrointestinal stromal tumours (GISTs). The Journal of Pathology. 217(1). 103–112. 17 indexed citations
20.
Miselli, Francesca, Tiziana Negri, Alessandro Gronchi, et al.. (2008). Is Autophagy Rather Than Apoptosis the Regression Driver in Imatinib-Treated Gastrointestinal Stromal Tumors?. Translational Oncology. 1(4). 177–186. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongying Zhang Breakdown of academic impact, for papers by Paul Chih-Hsueh Chen Breakdown of academic impact, for papers by Charles Forscher Breakdown of academic impact, for papers by Lu Xie Breakdown of academic impact, for papers by Lorenzo D’Ambrosio Breakdown of academic impact, for papers by Sebastian Dorin Asaftei Breakdown of academic impact, for papers by Paolo Cotzia Breakdown of academic impact, for papers by Konrad Ptaszyński Breakdown of academic impact, for papers by Kunkun Sun
Rankless by CCL
2026